Home/Filings/4/0001387131-16-003972
4//SEC Filing

Adamis Pharmaceuticals Corp 4

Accession 0001387131-16-003972

CIK 0000887247operating

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:19 PM ET

Size

5.5 KB

Accession

0001387131-16-003972

Insider Transaction Report

Form 4
Period: 2016-01-25
Moll Thomas
Vice President of Research
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-01-25+67,18367,183 total
    Exercise: $4.10Exp: 2026-01-25Common Stock (67,183 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000887247

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:19 PM ET
Size
5.5 KB